Literature DB >> 8639526

Determinants of cofactor specificity in isocitrate dehydrogenase: structure of an engineered NADP+ --> NAD+ specificity-reversal mutant.

J H Hurley1, R Chen, A M Dean.   

Abstract

The 7-fold mutation Cys201Met/Cys332Tyr/Lys344Asp/Tyr345Ile/Val35 1Ala/Tyr391Lys/Arg395Ser converts the cofactor specificity of Escherichia coli isocitrate dehydrogenase from a 7000-fold preference for NADP+ to a 200-fold preference for NAD+, with overall activity comparable to that of wild-type NAD+-dependent isocitrate dehydrogenases. The structure of the NAD+-dependent mutant has been determined and refined to a working R-factor of 0.186 at 1.9 A resolution. The structure shows that NADP+ affinity is destroyed by removing favorable interactions between the 2'-phosphate and Tyr345, Tyr391, and Arg395 and by adding a repulsive interaction with Asp344. NAD+ affinity is enhanced by adding hydrogen bonds between Asp344 and the free 2'-hydroxyl. The favorable Asp344-2'-OH interaction requires a change in the pucker of the ribose to C2' endo and a shift in the adenine ring. The ring shift is made possible by a series of changes in steric packing interactions. The linchpin for repacking in the adenosine binding site is residue 351. The side chain of this "second layer" residue dictates packing of the surrounding "first layer" residues which interact with the 2' moiety and, in turn, directly determine specificity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8639526     DOI: 10.1021/bi953001q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

1.  Functional prediction: identification of protein orthologs and paralogs.

Authors:  R Chen; S S Jeong
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

Review 2.  In Silico Constraint-Based Strain Optimization Methods: the Quest for Optimal Cell Factories.

Authors:  Paulo Maia; Miguel Rocha; Isabel Rocha
Journal:  Microbiol Mol Biol Rev       Date:  2015-11-25       Impact factor: 11.056

3.  Mutations in adenine-binding pockets enhance catalytic properties of NAD(P)H-dependent enzymes.

Authors:  J K B Cahn; A Baumschlager; S Brinkmann-Chen; F H Arnold
Journal:  Protein Eng Des Sel       Date:  2015-10-27       Impact factor: 1.650

4.  Complete reversal of coenzyme specificity of isocitrate dehydrogenase from Haloferax volcanii.

Authors:  Adoración Rodríguez-Arnedo; Mónica Camacho; Francisco Llorca; María-José Bonete
Journal:  Protein J       Date:  2005-07       Impact factor: 2.371

5.  Induced fit and the catalytic mechanism of isocitrate dehydrogenase.

Authors:  Susana Gonçalves; Stephen P Miller; Maria A Carrondo; Anthony M Dean; Pedro M Matias
Journal:  Biochemistry       Date:  2012-08-27       Impact factor: 3.162

6.  Structural plasticity of an aminoacyl-tRNA synthetase active site.

Authors:  James M Turner; James Graziano; Glen Spraggon; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-17       Impact factor: 11.205

7.  The coenzyme specificity of Candida tenuis xylose reductase (AKR2B5) explored by site-directed mutagenesis and X-ray crystallography.

Authors:  Barbara Petschacher; Stefan Leitgeb; Kathryn L Kavanagh; David K Wilson; Bernd Nidetzky
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

8.  Different biochemical mechanisms ensure network-wide balancing of reducing equivalents in microbial metabolism.

Authors:  Tobias Fuhrer; Uwe Sauer
Journal:  J Bacteriol       Date:  2009-01-30       Impact factor: 3.490

9.  Biochemical and Phylogenetic Characterization of a Novel NADP+-Specific Isocitrate Dehydrogenase From the Marine Microalga Phaeodactylum tricornutum.

Authors:  Shiping Huang; Jiaxin Zhao; Wenjing Li; Peng Wang; Zhenglian Xue; Guoping Zhu
Journal:  Front Mol Biosci       Date:  2021-07-05

10.  Isocitrate dehydrogenase from Streptococcus mutans: biochemical properties and evaluation of a putative phosphorylation site at Ser102.

Authors:  Peng Wang; Ping Song; Mingming Jin; Guoping Zhu
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.